https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=32331950&retmode=xml&tool=Litmetric&email=readroberts32@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09 323319502020092320200923
1545-15343122020JunWilderness & environmental medicineWilderness Environ MedReview of Scorpion Stings and Snakebites Treated by the French Military Health Service During Overseas Operations Between 2015 and 2017.174180174-18010.1016/j.wem.2020.01.006S1080-6032(20)30017-XDepending on their theatre of operation, French soldiers may potentially be exposed to scorpion stings and snakebites. Following the recommendations of a French military health service (FMHS) technical committee for envenomation, the FMHS provides antivenoms appropriate to each deployment. This work aimed to evaluate this risk of envenomation and to assess the antivenoms used by the FMHS in operational theatres since the creation of this committee in 2015.Cases were identified based on a review of temporary authorization of use application forms for the use of antivenom. Data were collected retrospectively from these forms, and prescribing physicians were contacted for any missing data.Between 2015 and 2017, 28 requests for temporary authorization of use were identified: 19 for Scorpifav (Sanofi-Pasteur, Lyon, France) and 9 for Fav-Afrique (Sanofi-Pasteur). The FMHS treated 15 soldiers and 4 civilians for scorpion envenomation with Scorpifav: 15 in Mali, 3 in Chad, and 1 in Niger. Systemic signs were observed in 7 patients. Two soldiers and 7 civilians were treated with Fav-Afrique for ophidian envenomation: 5 in Djibouti, 3 in Mali, and 1 in the Republic of Côte d'Ivoire. These 28 patients were treated without sequelae. Other than moderate erythema that resolved with an antihistamine, no adverse effects were reported. Medical evacuation to France was unnecessary.This study shows that the risk of envenomation for soldiers on deployment is low but real. Antivenoms used by the FMHS were efficient and well tolerated, preserving the operational capacity of deployed troops.Copyright © 2020 Wilderness Medical Society. Published by Elsevier Inc. All rights reserved.BombaAuroreAFrench Military Health Service Academy, Ecole du Val-de-Grâce, Paris, France.FavaroPascalPFrench Armed Forces Health Products Supply Directorate, Orléans, France.HausRachelRCentral Directorate of the French Military Health Service, Paris, France.AigleLucLFrench Military Health Service Academy, Ecole du Val-de-Grâce, Paris, France; 10(th) Military Medical Center, Aubagne, France.JeanFrançois-XavierFXDepartment of Anesthesiology and Intensive Care, Desgenettes Military Hospital, Lyon, France.DauphinIsabelleICentral Directorate of the French Military Health Service, Paris, France.GuigonPierrePFrench Armed Forces Health Products Supply Directorate, Orléans, France.FontaineBrunoBFrench Military Health Service Academy, Ecole du Val-de-Grâce, Paris, France; Department of Anesthesiology and Intensive Care, Robert Picqué Military Hospital, Bordeaux, France.PuidupinMarcMMilitary Health Service Academy, Libreville, Gabon.DemoncheauxJean-PaulJPCentral Directorate of the French Military Health Service, Paris, France.LarréchéSébastienSDepartment of Medical Biology, Bégin Military Hospital, Saint-Mandé, France. Electronic address: slarreche@hotmail.fr.engJournal Article20200421
United StatesWilderness Environ Med95051851080-60320AntiveninsIMAdultAntiveninstherapeutic useFemaleFranceepidemiologyHumansMaleMiddle AgedMilitary HealthMilitary Personnelstatistics & numerical dataRisk FactorsScorpion StingsepidemiologytherapySnake BitesepidemiologytherapyYoung AdultAfricaantivenomarmed forcesenvenomationsoldiers
20199420191222020115202042660202092460202042660ppublish3233195010.1016/j.wem.2020.01.006S1080-6032(20)30017-X